School of Medicine
Showing 3,751-3,800 of 12,927 Results
-
Alan M Glaseroff
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Alan Glaseroff served as the Director of Workforce Transformation in Primary Care at Stanford from the fall of 2015 until mid-June of 2016, where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care underway in 2016. He will be joining the faculty at Stanford's Clinical Excellence Research Center this summer, working with Dr. Arnie Milstein to help develop new models of care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness from 2011 to the end of 2015. Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative and served as a a Clinical Advisor to the PBGH “Intensive Outpatient Care Program” CMMI Innovation Grant that completes in June 2015. He served on the NCQA Patient-Centered Medical Home Advisory Committee 2009-2010, and the “Let’s Get Healthy California” expert task force in 2012,. Dr. Glaseroff was named the California Family Physician of the Year for 2009.
Dr. Glaseroff’s interests focus on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
The Coordinated Care clinic is an exclusive benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions.
Please complete the Coordinated Care self-assessment to determine eligibility based on health condition(s) and health insurance: https://stanfordmedicine.qualtrics.com/SE/?SID=SV_2siBNrfJ8zmn3GB -
Greg Glasscock
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsNeonatal Endocrinology
-
Jeffrey S. Glenn, M.D., Ph.D.
Joseph D. Grant Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsDr. Glenn's primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Other interests include exploitation of hepatic stem cells, engineered human liver tissues, liver cancer, and new biodefense antiviral strategies.
-
Natasha Abadilla Glenn
Resident in Adult Neurology
Affiliate, Department FundsCurrent Research and Scholarly Interestsglobal health, public health, health disparities, advocacy, pediatric neurology
-
Giancarlo Glick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
-
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
-
Gary Glover
Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Psychology and of Electrical Engineering
Current Research and Scholarly InterestsMy present research is devoted to the advancement of functional magnetic resonance imaging sciences for applications in basic understanding of the brain in health and disease. We collaborate closely with departmental clinicians and with others in the school of medicine, humanities, and the engineering sciences.
-
Anna L Gloyn
Professor of Pediatrics (Endocrinology) and of Genetics
Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.
-
Thomas Glynn
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award. -
Kavin Gobinath
Affiliate, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
BioStudent researcher focused on early cancer detection, developed biomedical device that analyze breath-based biomarkers to identify lung cancer at its earliest stages.
-
Aparna Goel
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.
She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others. -
Amit Gohil
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Staff, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioMy main practice is at County Hospital of Santa Clara, where my time is split between Pulmonary Clinic, Pulmonary Physiology Lab and Medical Intensive Care.
Other Clinical Interests include neurocritical care, Mab therapy for asthma,. and management of toxin induced pulmonary hypertension
My research interests are moving into the use of Data Science to answer clinical questions. I am currently in the process of becoming familiar with R as a coding language to examine large clinical data sets and hope to move into machine learning algorithms to improve the pulmonary health of our county population. -
Lauren Goins
Assistant Professor of Developmental Biology
Current Research and Scholarly InterestsThe Goins lab aims to understand how cells make decisions. Our research focuses on how young, immature blood stem cells, with the potential to become many different cell types, choose between these cell fates.
-
Carl Gold
Clinical Associate Professor, Adult Neurology
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Gold is a board-certified neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer.
Dr. Gold serves as Vice Chair of Quality, Safety, & Experience for the Department of Neurology & Neurological Sciences. In this role, he coordinates projects aimed at improving care for patients with neurological conditions across the health system. He also serves as Medical Director of Service Excellence for Stanford Health Care.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html
Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html -
Garry Gold
Stanford Medicine Professor of Radiology and Biomedical Imaging
Current Research and Scholarly InterestsMy primary focus is application of new MR imaging technology to musculoskeletal problems. Current projects include: Rapid MRI for Osteoarthritis, Weight-bearing cartilage imaging with MRI, and MRI-based models of muscle. We are studying the application of new MR imaging techniques such as rapid imaging, real-time imaging, and short echo time imaging to learn more about biomechanics and pathology of bones and joints. I am also interested in functional imaging approaches using PET-MRI.
-
Jeffrey Goldberg, MD, PhD
Blumenkranz Smead Professor
Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.
-
Olga Fedin Goldberg
Clinical Associate Professor, Adult Neurology
BioDr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.
-
Neville H. Golden M.D.
Marron and Mary Elizabeth Kendrick Professor of Pediatrics, Emeritus
Current Research and Scholarly InterestsMy research has focused on the medical complications of adolescents with eating disorders. My specific area of study has been the etiology and implications of amenorrhea in adolescents with eating disorders, in particular the management of reduced bone mass and osteoporosis in anorexia nervosa.
-
David Edward Goldenberg
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr Goldenberg completed training at UCLA, Geisel School of Medicine at Dartmouth, Tufts Medical Center, and Cedars Sinai Medical Center. In addition to a gastroenterology fellowship, he graduated with a Masters in Healthcare Delivery Science at Cedars Sinai Medical Center. He has a passion for medical education and enjoys teaching medical students, residents, and fellows as a Clinician Educator. His research focuses on Healthcare Delivery with an emphasis on maximizing value-based healthcare and medical innovation. He has an additional interest in translational research with multiple publications and patent applications for medical devices. He has unique clinical expertise in fecal microbiota transplantation.
-
Ilona Telefus Goldfarb, MD, MPH
Clinical Associate Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
Current Research and Scholarly InterestsManagement of patients with postpartum hypertension using at-home technology
-
Jeremy Goldhaber-Fiebert
Professor of Health Policy
BioJeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy and a Core Faculty Member in the Centers for Health Policy and Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021.
Past and current research topics:
- Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.
-Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.
- Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.
- Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.
- Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity. -
Sara Goldhaber-Fiebert
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy teams' interests are in improving patient safety, harnessing implementation science and medical simulation techniques for training, development, dissemination, implementation and study of these processes. We collaborate nationally and globally on implementation of emergency manuals (context relevant sets of cognitive aids or crisis checklists), for management of crises and freely share team training resources. See http://emergencymanual.stanford.edu and www.emergencymanuals.org
